PERSPECTIVE THERAPEUTICS INC (CATX) Stock Earnings Estimates
NYSEARCA:CATX • US46489V3024
5.02 USD
+0.14 (+2.87%)
At close: Feb 12, 2026
5.1573 USD
+0.14 (+2.74%)
After Hours: 2/12/2026, 8:04:00 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.8M 7.46% | 1.434M -86.72% | 1.454M 1.39% | 1.123M -22.76% | 894.336K -20.36% | 624.883K -30.13% | 25.484M 3,978.21% | 277.26M 987.98% | 259.25M -6.50% | 422.84M 63.10% | 574.06M 35.76% | 740.82M 29.05% | |
| EBITDA YoY % growth | -7.1M -118.46% | -39.955M -462.75% | -64.491M -61.41% | -103.851M -61.03% | -117.203M -12.86% | -97.706M 16.64% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -7.39M -114.83% | -40.941M -454.01% | -66.797M -63.15% | -103.37M -54.75% | -125.076M -21.00% | -134.729M -7.72% | -156.27M -15.99% | 44.881M 128.72% | 50.027M 11.47% | 178.84M 257.49% | 305.58M 70.87% | 443.09M 45.00% | |
| Operating Margin | -68.43% | -2,855.02% | -4,594.02% | -9,204.80% | -13,985.34% | -21,560.65% | -613.21% | 16.19% | 19.30% | 42.29% | 53.23% | 59.81% | |
| EPS YoY % growth | -0.05 -25.00% | N/A -2,619.93% | -0.84 38.23% | -1.28 -52.53% | -1.34 -4.65% | -1.19 11.37% | -1.16 2.79% | -1.00 13.02% | -0.69 30.96% | -0.05 93.38% | 0.65 1,511.11% | 1.25 92.91% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.36 -44.64% | -0.39 -55.52% | -0.37 -26.21% | -0.39 -12.20% | -0.39 -8.98% |
| Revenue Q2Q % growth | 238.252K 1.82% | 179.928K -47.39% | 153K -47.24% | 132.6K -36.56% | 132.6K -44.34% |
| EBITDA Q2Q % growth | -30.503M -64.09% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -29.838M -42.80% | -30.866M -41.38% | -31.14M -29.54% | -32.848M -17.90% | -32.438M -8.71% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.35 -66.67% | -0.33 | -0.02 | -5.16% |
| Q2 2025 Q2Q % growth | -0.29 -61.11% | -0.31 | 0.02 | 5.80% |
| Q1 2025 Q2Q % growth | -0.25 -25.00% | -0.31 | 0.06 | 20.23% |
| Q4 2024 Q2Q % growth | -0.25 71.59% | -0.27 | 0.02 | 7.98% |
| Q3 2024 Q2Q % growth | -0.21 47.50% | -0.22 | 0.01 | 3.49% |
| Q2 2024 Q2Q % growth | -0.18 -800.00% | -0.21 | 0.03 | 15.97% |
| Q1 2024 Q2Q % growth | -0.20 | -0.24 | 0.04 | 15.95% |
| Q4 2023 Q2Q % growth | -0.88 -8,700.00% | -0.37 | -0.51 | -135.27% |
| Q3 2023 Q2Q % growth | -0.40 -3,900.00% | -0.41 | 0.01 | 1.96% |
| Q2 2023 Q2Q % growth | -0.02 -100.00% | -0.01 | -0.01 | -96.08% |
| Q4 2022 Q2Q % growth | -0.01 | -0.01 | 0.00 | 1.96% |
| Q3 2022 Q2Q % growth | -0.01 | -0.01 | 0.00 | -30.72% |
| Q2 2022 Q2Q % growth | -0.01 | -0.01 | 0.00 | -30.72% |
| Q1 2022 Q2Q % growth | -0.02 -100.00% | -0.01 | -0.01 | -96.08% |
| Q4 2021 Q2Q % growth | -0.01 50.00% | -0.01 | 0.00 | 1.96% |
| Q3 2021 Q2Q % growth | -0.01 | -0.01 | 0.00 | 1.96% |
| Q2 2021 Q2Q % growth | -0.01 | -0.01 | 0.00 | 1.96% |
| Q1 2021 Q2Q % growth | -0.01 | -0.01 | 0.00 | 1.96% |
| Q4 2020 Q2Q % growth | -0.02 | -0.02 | 0.00 | -30.72% |
| Q3 2020 Q2Q % growth | -0.01 | -0.01 | 0.00 | 26.45% |
| Q2 2020 Q2Q % growth | -0.01 | -0.01 | 0.00 | 26.45% |
| Q1 2020 Q2Q % growth | -0.01 | -0.02 | 0.01 | 50.98% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 209K -43.36% | 228.307K | -19.307K | -8.46% |
| Q2 2025 Q2Q % growth | 290K -44.87% | 157.549K | 132.451K | 84.07% |
| Q1 2025 Q2Q % growth | 342K 5.23% | 147.186K | 194.814K | 132.36% |
| Q4 2024 Q2Q % growth | 234K -88.50% | 249.064K | -15.064K | -6.05% |
| Q3 2024 Q2Q % growth | 369K -83.11% | 269.392K | 99.608K | 36.98% |
| Q2 2024 Q2Q % growth | 526K -74.83% | 161.843K | 364.157K | 225.01% |
| Q1 2024 Q2Q % growth | 325K -84.22% | 325K | % | |
| Q4 2023 Q2Q % growth | 2.034M 10.54% | 1.953M | 81K | 4.15% |
| Q3 2023 Q2Q % growth | 2.185M 27.03% | 2.244M | -59K | -2.63% |
| Q2 2023 Q2Q % growth | 2.09M -16.73% | % | ||
| Q1 2023 Q2Q % growth | 2.06M -29.21% | % | ||
| Q4 2022 Q2Q % growth | 1.84M -34.75% | 2.901M | -1.061M | -36.57% |
| Q3 2022 Q2Q % growth | 1.72M -32.81% | 3.175M | -1.455M | -45.83% |
| Q2 2022 Q2Q % growth | 2.51M -7.38% | 3.008M | -498K | -16.56% |
| Q1 2022 Q2Q % growth | 2.91M 11.92% | 2.535M | 375K | 14.79% |
| Q4 2021 Q2Q % growth | 2.82M 19.49% | 2.754M | 66K | 2.40% |
| Q3 2021 Q2Q % growth | 2.56M 7.56% | 2.475M | 85K | 3.43% |
| Q2 2021 Q2Q % growth | 2.71M 18.86% | 2.433M | 277K | 11.39% |
| Q1 2021 Q2Q % growth | 2.6M -9.72% | 2.911M | -311K | -10.68% |
| Q4 2020 Q2Q % growth | 2.36M | 2.754M | -394K | -14.31% |
| Q3 2020 Q2Q % growth | 2.38M | 2.605M | -225K | -8.64% |
| Q2 2020 Q2Q % growth | 2.28M | 2.352M | -72K | -3.06% |
| Q1 2020 Q2Q % growth | 2.88M | 1.989M | 891K | 44.80% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.64% | -5.19% | -1.17% | -5.02% |
| Revenue | 5.61% | 3.73% | 0% | -3.11% |